Bender Robert & Associates Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bender Robert & Associates cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 72,661 shares of the medical equipment provider’s stock after selling 11,754 shares during the period. Intuitive Surgical comprises approximately 9.2% of Bender Robert & Associates’ holdings, making the stock its 3rd largest holding. Bender Robert & Associates’ holdings in Intuitive Surgical were worth $37,926,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Bennett Selby Investments LP raised its position in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares in the last quarter. Onefund LLC raised its position in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after buying an additional 18 shares in the last quarter. LVW Advisors LLC raised its position in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its position in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC raised its position in Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,309 shares of company stock valued at $7,611,004. 0.90% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have commented on ISRG. Truist Financial boosted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Barclays boosted their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Evercore ISI boosted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Trading Up 2.3 %

Shares of ISRG opened at $493.72 on Wednesday. The stock has a market capitalization of $175.85 billion, a P/E ratio of 77.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm’s fifty day simple moving average is $569.91 and its two-hundred day simple moving average is $531.84. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.